nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR1D—meninx—malignant glioma	0.0372	0.0997	CbGeAlD
Pergolide—HTR1B—dura mater—malignant glioma	0.0354	0.0948	CbGeAlD
Pergolide—HTR1D—dura mater—malignant glioma	0.0343	0.0918	CbGeAlD
Pergolide—HTR2C—choroid plexus—malignant glioma	0.0289	0.0773	CbGeAlD
Pergolide—DRD3—telencephalic ventricle—malignant glioma	0.0152	0.0407	CbGeAlD
Pergolide—HTR2A—choroid plexus—malignant glioma	0.0145	0.0388	CbGeAlD
Pergolide—DRD1—telencephalic ventricle—malignant glioma	0.0109	0.0291	CbGeAlD
Pergolide—Brain oedema—Carmustine—malignant glioma	0.00968	0.022	CcSEcCtD
Pergolide—Brain oedema—Temozolomide—malignant glioma	0.00935	0.0212	CcSEcCtD
Pergolide—HTR1B—telencephalic ventricle—malignant glioma	0.00882	0.0236	CbGeAlD
Pergolide—Facial paralysis—Carmustine—malignant glioma	0.0087	0.0197	CcSEcCtD
Pergolide—HTR1D—telencephalic ventricle—malignant glioma	0.00854	0.0229	CbGeAlD
Pergolide—HTR2C—telencephalic ventricle—malignant glioma	0.00845	0.0226	CbGeAlD
Pergolide—Hemiplegia—Carmustine—malignant glioma	0.00774	0.0176	CcSEcCtD
Pergolide—Hemiplegia—Temozolomide—malignant glioma	0.00748	0.017	CcSEcCtD
Pergolide—HTR2A—cerebellar cortex—malignant glioma	0.00729	0.0195	CbGeAlD
Pergolide—Meningitis—Carmustine—malignant glioma	0.00713	0.0162	CcSEcCtD
Pergolide—HTR1A—telencephalic ventricle—malignant glioma	0.00712	0.0191	CbGeAlD
Pergolide—VIIth nerve paralysis—Carmustine—malignant glioma	0.00674	0.0153	CcSEcCtD
Pergolide—Intracranial pressure increased—Carmustine—malignant glioma	0.00662	0.015	CcSEcCtD
Pergolide—Paranoid reaction—Carmustine—malignant glioma	0.00651	0.0148	CcSEcCtD
Pergolide—DRD2—telencephalic ventricle—malignant glioma	0.00643	0.0172	CbGeAlD
Pergolide—Personality disorder—Carmustine—malignant glioma	0.00639	0.0145	CcSEcCtD
Pergolide—Pulmonary fibrosis—Carmustine—malignant glioma	0.00629	0.0143	CcSEcCtD
Pergolide—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00608	0.0138	CcSEcCtD
Pergolide—Cerebral ischaemia—Temozolomide—malignant glioma	0.00553	0.0125	CcSEcCtD
Pergolide—Faecal incontinence—Carmustine—malignant glioma	0.00548	0.0124	CcSEcCtD
Pergolide—Faecal incontinence—Temozolomide—malignant glioma	0.0053	0.012	CcSEcCtD
Pergolide—HTR2A—pons—malignant glioma	0.00515	0.0138	CbGeAlD
Pergolide—HTR2A—vertebral column—malignant glioma	0.00512	0.0137	CbGeAlD
Pergolide—Cerebral haemorrhage—Carmustine—malignant glioma	0.005	0.0113	CcSEcCtD
Pergolide—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00483	0.011	CcSEcCtD
Pergolide—HTR1B—blood vessel—malignant glioma	0.00437	0.0117	CbGeAlD
Pergolide—HTR2A—telencephalic ventricle—malignant glioma	0.00424	0.0114	CbGeAlD
Pergolide—HTR1D—blood vessel—malignant glioma	0.00423	0.0113	CbGeAlD
Pergolide—Hypokinesia—Carmustine—malignant glioma	0.0041	0.0093	CcSEcCtD
Pergolide—Paranoia—Carmustine—malignant glioma	0.00406	0.00921	CcSEcCtD
Pergolide—Apathy—Temozolomide—malignant glioma	0.00374	0.00849	CcSEcCtD
Pergolide—Flat affect—Temozolomide—malignant glioma	0.00371	0.00841	CcSEcCtD
Pergolide—Stupor—Carmustine—malignant glioma	0.0037	0.00841	CcSEcCtD
Pergolide—HTR2A—pineal body—malignant glioma	0.00368	0.00985	CbGeAlD
Pergolide—Scotoma—Carmustine—malignant glioma	0.00364	0.00826	CcSEcCtD
Pergolide—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00361	0.00819	CcSEcCtD
Pergolide—Menorrhagia—Temozolomide—malignant glioma	0.00361	0.00819	CcSEcCtD
Pergolide—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00355	0.00805	CcSEcCtD
Pergolide—Herpes zoster—Temozolomide—malignant glioma	0.00355	0.00805	CcSEcCtD
Pergolide—Scotoma—Temozolomide—malignant glioma	0.00352	0.00799	CcSEcCtD
Pergolide—Abscess—Carmustine—malignant glioma	0.0035	0.00793	CcSEcCtD
Pergolide—Otitis media—Temozolomide—malignant glioma	0.00343	0.00779	CcSEcCtD
Pergolide—DRD5—telencephalon—malignant glioma	0.00342	0.00916	CbGeAlD
Pergolide—Petechiae—Temozolomide—malignant glioma	0.00325	0.00737	CcSEcCtD
Pergolide—Endocrine disorder—Temozolomide—malignant glioma	0.00322	0.00732	CcSEcCtD
Pergolide—Speech disorder—Carmustine—malignant glioma	0.00322	0.0073	CcSEcCtD
Pergolide—Accidental injury—Carmustine—malignant glioma	0.00313	0.00709	CcSEcCtD
Pergolide—Speech disorder—Temozolomide—malignant glioma	0.00311	0.00705	CcSEcCtD
Pergolide—Breast pain—Temozolomide—malignant glioma	0.00306	0.00695	CcSEcCtD
Pergolide—Amenorrhoea—Temozolomide—malignant glioma	0.00304	0.0069	CcSEcCtD
Pergolide—Thinking abnormal—Carmustine—malignant glioma	0.00302	0.00685	CcSEcCtD
Pergolide—DRD1—brainstem—malignant glioma	0.00294	0.00789	CbGeAlD
Pergolide—Leukocytosis—Carmustine—malignant glioma	0.00294	0.00668	CcSEcCtD
Pergolide—Herpes simplex—Temozolomide—malignant glioma	0.0029	0.00658	CcSEcCtD
Pergolide—Gait disturbance—Carmustine—malignant glioma	0.00283	0.00643	CcSEcCtD
Pergolide—Coordination abnormal—Carmustine—malignant glioma	0.00282	0.00639	CcSEcCtD
Pergolide—Neck pain—Carmustine—malignant glioma	0.0028	0.00635	CcSEcCtD
Pergolide—Pulmonary embolism—Carmustine—malignant glioma	0.00277	0.00628	CcSEcCtD
Pergolide—ADRA1D—telencephalon—malignant glioma	0.00274	0.00734	CbGeAlD
Pergolide—Gait disturbance—Temozolomide—malignant glioma	0.00274	0.00621	CcSEcCtD
Pergolide—Respiratory failure—Temozolomide—malignant glioma	0.00272	0.00618	CcSEcCtD
Pergolide—Coordination abnormal—Temozolomide—malignant glioma	0.00272	0.00618	CcSEcCtD
Pergolide—Pulmonary embolism—Temozolomide—malignant glioma	0.00267	0.00606	CcSEcCtD
Pergolide—Vaginal inflammation—Temozolomide—malignant glioma	0.00267	0.00606	CcSEcCtD
Pergolide—Urinary incontinence—Carmustine—malignant glioma	0.00267	0.00606	CcSEcCtD
Pergolide—Depressed level of consciousness—Carmustine—malignant glioma	0.00267	0.00606	CcSEcCtD
Pergolide—Candida infection—Carmustine—malignant glioma	0.00264	0.00599	CcSEcCtD
Pergolide—DRD1—telencephalon—malignant glioma	0.00261	0.007	CbGeAlD
Pergolide—Neuropathy—Carmustine—malignant glioma	0.0026	0.00589	CcSEcCtD
Pergolide—Depressed level of consciousness—Temozolomide—malignant glioma	0.00258	0.00586	CcSEcCtD
Pergolide—Urinary incontinence—Temozolomide—malignant glioma	0.00258	0.00586	CcSEcCtD
Pergolide—Candida infection—Temozolomide—malignant glioma	0.00255	0.00579	CcSEcCtD
Pergolide—Coma—Carmustine—malignant glioma	0.00253	0.00573	CcSEcCtD
Pergolide—Vaginal infection—Temozolomide—malignant glioma	0.00252	0.00573	CcSEcCtD
Pergolide—Neuropathy—Temozolomide—malignant glioma	0.00251	0.00569	CcSEcCtD
Pergolide—Neoplasm—Carmustine—malignant glioma	0.0025	0.00567	CcSEcCtD
Pergolide—Neoplasm—Temozolomide—malignant glioma	0.00242	0.00548	CcSEcCtD
Pergolide—Abnormal vision—Carmustine—malignant glioma	0.00241	0.00547	CcSEcCtD
Pergolide—Mental disability—Carmustine—malignant glioma	0.0024	0.00545	CcSEcCtD
Pergolide—Sepsis—Carmustine—malignant glioma	0.0024	0.00545	CcSEcCtD
Pergolide—HTR1B—brainstem—malignant glioma	0.00239	0.00639	CbGeAlD
Pergolide—DRD4—brain—malignant glioma	0.00234	0.00627	CbGeAlD
Pergolide—Abnormal vision—Temozolomide—malignant glioma	0.00233	0.00529	CcSEcCtD
Pergolide—Mental disability—Temozolomide—malignant glioma	0.00232	0.00526	CcSEcCtD
Pergolide—Thrombophlebitis—Carmustine—malignant glioma	0.00232	0.00526	CcSEcCtD
Pergolide—HTR1D—brainstem—malignant glioma	0.00231	0.00619	CbGeAlD
Pergolide—Diabetes mellitus—Carmustine—malignant glioma	0.00231	0.00524	CcSEcCtD
Pergolide—HTR2C—brainstem—malignant glioma	0.00229	0.00613	CbGeAlD
Pergolide—HTR2A—endothelium—malignant glioma	0.00228	0.0061	CbGeAlD
Pergolide—Ear pain—Temozolomide—malignant glioma	0.00227	0.00516	CcSEcCtD
Pergolide—Thrombophlebitis—Temozolomide—malignant glioma	0.00224	0.00509	CcSEcCtD
Pergolide—Eye pain—Carmustine—malignant glioma	0.00222	0.00505	CcSEcCtD
Pergolide—Gastroenteritis—Temozolomide—malignant glioma	0.00219	0.00497	CcSEcCtD
Pergolide—Injury—Carmustine—malignant glioma	0.00218	0.00496	CcSEcCtD
Pergolide—Deafness—Temozolomide—malignant glioma	0.00217	0.00492	CcSEcCtD
Pergolide—Vascular purpura—Temozolomide—malignant glioma	0.00217	0.00492	CcSEcCtD
Pergolide—Eye pain—Temozolomide—malignant glioma	0.00215	0.00488	CcSEcCtD
Pergolide—Amnesia—Carmustine—malignant glioma	0.00214	0.00485	CcSEcCtD
Pergolide—HTR1B—telencephalon—malignant glioma	0.00212	0.00567	CbGeAlD
Pergolide—HTR2A—blood vessel—malignant glioma	0.0021	0.00562	CbGeAlD
Pergolide—DRD3—central nervous system—malignant glioma	0.00207	0.00556	CbGeAlD
Pergolide—Amnesia—Temozolomide—malignant glioma	0.00206	0.00469	CcSEcCtD
Pergolide—HTR1D—telencephalon—malignant glioma	0.00205	0.00549	CbGeAlD
Pergolide—Thirst—Temozolomide—malignant glioma	0.00204	0.00463	CcSEcCtD
Pergolide—HTR2C—telencephalon—malignant glioma	0.00203	0.00544	CbGeAlD
Pergolide—Purpura—Temozolomide—malignant glioma	0.00201	0.00457	CcSEcCtD
Pergolide—Diplopia—Carmustine—malignant glioma	0.00201	0.00456	CcSEcCtD
Pergolide—DRD5—central nervous system—malignant glioma	0.00194	0.00521	CbGeAlD
Pergolide—Diplopia—Temozolomide—malignant glioma	0.00194	0.0044	CcSEcCtD
Pergolide—Face oedema—Carmustine—malignant glioma	0.00194	0.0044	CcSEcCtD
Pergolide—HTR1A—brainstem—malignant glioma	0.00193	0.00516	CbGeAlD
Pergolide—Affect lability—Temozolomide—malignant glioma	0.00191	0.00433	CcSEcCtD
Pergolide—HTR2B—telencephalon—malignant glioma	0.00191	0.00511	CbGeAlD
Pergolide—Ataxia—Carmustine—malignant glioma	0.00189	0.00428	CcSEcCtD
Pergolide—DRD1—midbrain—malignant glioma	0.00188	0.00503	CbGeAlD
Pergolide—Face oedema—Temozolomide—malignant glioma	0.00187	0.00425	CcSEcCtD
Pergolide—Liver function test abnormal—Carmustine—malignant glioma	0.00185	0.00421	CcSEcCtD
Pergolide—Mood swings—Temozolomide—malignant glioma	0.00184	0.00417	CcSEcCtD
Pergolide—Hypokalaemia—Carmustine—malignant glioma	0.00183	0.00415	CcSEcCtD
Pergolide—Ataxia—Temozolomide—malignant glioma	0.00182	0.00414	CcSEcCtD
Pergolide—Dehydration—Temozolomide—malignant glioma	0.0018	0.00409	CcSEcCtD
Pergolide—Dry skin—Temozolomide—malignant glioma	0.00178	0.00404	CcSEcCtD
Pergolide—ADRA1A—brainstem—malignant glioma	0.00178	0.00475	CbGeAlD
Pergolide—Hypokalaemia—Temozolomide—malignant glioma	0.00177	0.00401	CcSEcCtD
Pergolide—DRD2—brainstem—malignant glioma	0.00174	0.00466	CbGeAlD
Pergolide—Dysphagia—Carmustine—malignant glioma	0.00174	0.00394	CcSEcCtD
Pergolide—HTR1A—telencephalon—malignant glioma	0.00171	0.00458	CbGeAlD
Pergolide—Abdominal distension—Temozolomide—malignant glioma	0.00169	0.00383	CcSEcCtD
Pergolide—DRD2—retina—malignant glioma	0.00168	0.0045	CbGeAlD
Pergolide—Dysphagia—Temozolomide—malignant glioma	0.00168	0.0038	CcSEcCtD
Pergolide—DRD3—brain—malignant glioma	0.00165	0.00441	CbGeAlD
Pergolide—Bronchitis—Temozolomide—malignant glioma	0.00161	0.00366	CcSEcCtD
Pergolide—HTR2C—medulla oblongata—malignant glioma	0.0016	0.00427	CbGeAlD
Pergolide—ADRA1B—central nervous system—malignant glioma	0.00159	0.00427	CbGeAlD
Pergolide—ADRA1A—telencephalon—malignant glioma	0.00158	0.00422	CbGeAlD
Pergolide—Dysuria—Temozolomide—malignant glioma	0.00157	0.00356	CcSEcCtD
Pergolide—Hyperglycaemia—Carmustine—malignant glioma	0.00157	0.00355	CcSEcCtD
Pergolide—ADRA1D—central nervous system—malignant glioma	0.00156	0.00417	CbGeAlD
Pergolide—Pneumonia—Carmustine—malignant glioma	0.00156	0.00353	CcSEcCtD
Pergolide—Pollakiuria—Temozolomide—malignant glioma	0.00155	0.00351	CcSEcCtD
Pergolide—Erectile dysfunction—Temozolomide—malignant glioma	0.00154	0.0035	CcSEcCtD
Pergolide—DRD2—telencephalon—malignant glioma	0.00154	0.00413	CbGeAlD
Pergolide—DRD5—brain—malignant glioma	0.00154	0.00413	CbGeAlD
Pergolide—Depression—Carmustine—malignant glioma	0.00154	0.0035	CcSEcCtD
Pergolide—Weight increased—Temozolomide—malignant glioma	0.00153	0.00346	CcSEcCtD
Pergolide—KCNH2—telencephalon—malignant glioma	0.00152	0.00407	CbGeAlD
Pergolide—Renal failure—Carmustine—malignant glioma	0.00152	0.00345	CcSEcCtD
Pergolide—HTR1B—midbrain—malignant glioma	0.00152	0.00407	CbGeAlD
Pergolide—Weight decreased—Temozolomide—malignant glioma	0.00152	0.00344	CcSEcCtD
Pergolide—Neuropathy peripheral—Carmustine—malignant glioma	0.00152	0.00344	CcSEcCtD
Pergolide—Hyperglycaemia—Temozolomide—malignant glioma	0.00151	0.00343	CcSEcCtD
Pergolide—Urinary tract infection—Carmustine—malignant glioma	0.0015	0.00341	CcSEcCtD
Pergolide—Pneumonia—Temozolomide—malignant glioma	0.0015	0.00341	CcSEcCtD
Pergolide—ADRA2C—telencephalon—malignant glioma	0.0015	0.00402	CbGeAlD
Pergolide—Depression—Temozolomide—malignant glioma	0.00149	0.00338	CcSEcCtD
Pergolide—DRD1—central nervous system—malignant glioma	0.00149	0.00398	CbGeAlD
Pergolide—HTR1B—spinal cord—malignant glioma	0.00148	0.00397	CbGeAlD
Pergolide—HTR1D—midbrain—malignant glioma	0.00147	0.00394	CbGeAlD
Pergolide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00147	0.00333	CcSEcCtD
Pergolide—HTR2C—midbrain—malignant glioma	0.00146	0.0039	CbGeAlD
Pergolide—Urinary tract infection—Temozolomide—malignant glioma	0.00145	0.0033	CcSEcCtD
Pergolide—HTR2C—spinal cord—malignant glioma	0.00142	0.00381	CbGeAlD
Pergolide—Sinusitis—Temozolomide—malignant glioma	0.0014	0.00318	CcSEcCtD
Pergolide—Hallucination—Carmustine—malignant glioma	0.00138	0.00314	CcSEcCtD
Pergolide—Oedema peripheral—Carmustine—malignant glioma	0.00137	0.0031	CcSEcCtD
Pergolide—Hepatitis—Temozolomide—malignant glioma	0.00134	0.00305	CcSEcCtD
Pergolide—Visual impairment—Carmustine—malignant glioma	0.00134	0.00304	CcSEcCtD
Pergolide—Hallucination—Temozolomide—malignant glioma	0.00134	0.00303	CcSEcCtD
Pergolide—Pharyngitis—Temozolomide—malignant glioma	0.00133	0.00302	CcSEcCtD
Pergolide—Oedema peripheral—Temozolomide—malignant glioma	0.00132	0.003	CcSEcCtD
Pergolide—Eye disorder—Carmustine—malignant glioma	0.0013	0.00295	CcSEcCtD
Pergolide—Visual impairment—Temozolomide—malignant glioma	0.00129	0.00293	CcSEcCtD
Pergolide—ADRA1B—brain—malignant glioma	0.00127	0.00339	CbGeAlD
Pergolide—Eye disorder—Temozolomide—malignant glioma	0.00125	0.00285	CcSEcCtD
Pergolide—HTR2A—embryo—malignant glioma	0.00125	0.00335	CbGeAlD
Pergolide—Tinnitus—Temozolomide—malignant glioma	0.00125	0.00284	CcSEcCtD
Pergolide—Arrhythmia—Carmustine—malignant glioma	0.00124	0.00282	CcSEcCtD
Pergolide—ADRA1D—brain—malignant glioma	0.00124	0.00331	CbGeAlD
Pergolide—Alopecia—Carmustine—malignant glioma	0.00123	0.00278	CcSEcCtD
Pergolide—HTR1A—midbrain—malignant glioma	0.00123	0.00329	CbGeAlD
Pergolide—Chills—Temozolomide—malignant glioma	0.0012	0.00273	CcSEcCtD
Pergolide—HTR1B—central nervous system—malignant glioma	0.0012	0.00322	CbGeAlD
Pergolide—ADRA2A—telencephalon—malignant glioma	0.0012	0.00321	CbGeAlD
Pergolide—HTR1A—spinal cord—malignant glioma	0.0012	0.00321	CbGeAlD
Pergolide—KCNH2—medulla oblongata—malignant glioma	0.0012	0.0032	CbGeAlD
Pergolide—Alopecia—Temozolomide—malignant glioma	0.00119	0.00269	CcSEcCtD
Pergolide—ADRA2C—medulla oblongata—malignant glioma	0.00118	0.00316	CbGeAlD
Pergolide—DRD1—brain—malignant glioma	0.00118	0.00316	CbGeAlD
Pergolide—Back pain—Carmustine—malignant glioma	0.00117	0.00265	CcSEcCtD
Pergolide—HTR1D—central nervous system—malignant glioma	0.00117	0.00312	CbGeAlD
Pergolide—HTR2C—central nervous system—malignant glioma	0.00115	0.00309	CbGeAlD
Pergolide—HTR2A—brainstem—malignant glioma	0.00115	0.00307	CbGeAlD
Pergolide—Dysgeusia—Temozolomide—malignant glioma	0.00114	0.0026	CcSEcCtD
Pergolide—Tremor—Carmustine—malignant glioma	0.00113	0.00257	CcSEcCtD
Pergolide—Back pain—Temozolomide—malignant glioma	0.00113	0.00256	CcSEcCtD
Pergolide—Anaemia—Carmustine—malignant glioma	0.00112	0.00254	CcSEcCtD
Pergolide—Agitation—Carmustine—malignant glioma	0.00111	0.00252	CcSEcCtD
Pergolide—DRD2—midbrain—malignant glioma	0.00111	0.00297	CbGeAlD
Pergolide—HTR2A—retina—malignant glioma	0.00111	0.00296	CbGeAlD
Pergolide—Tremor—Temozolomide—malignant glioma	0.00109	0.00248	CcSEcCtD
Pergolide—KCNH2—midbrain—malignant glioma	0.00109	0.00293	CbGeAlD
Pergolide—Ill-defined disorder—Temozolomide—malignant glioma	0.00108	0.00246	CcSEcCtD
Pergolide—HTR2B—central nervous system—malignant glioma	0.00108	0.0029	CbGeAlD
Pergolide—Leukopenia—Carmustine—malignant glioma	0.00108	0.00246	CcSEcCtD
Pergolide—Anaemia—Temozolomide—malignant glioma	0.00108	0.00245	CcSEcCtD
Pergolide—ADRA2C—midbrain—malignant glioma	0.00108	0.00289	CbGeAlD
Pergolide—Agitation—Temozolomide—malignant glioma	0.00107	0.00244	CcSEcCtD
Pergolide—KCNH2—spinal cord—malignant glioma	0.00107	0.00285	CbGeAlD
Pergolide—Malaise—Temozolomide—malignant glioma	0.00105	0.00239	CcSEcCtD
Pergolide—ADRA2C—spinal cord—malignant glioma	0.00105	0.00282	CbGeAlD
Pergolide—Vertigo—Temozolomide—malignant glioma	0.00105	0.00238	CcSEcCtD
Pergolide—Convulsion—Carmustine—malignant glioma	0.00105	0.00238	CcSEcCtD
Pergolide—Leukopenia—Temozolomide—malignant glioma	0.00105	0.00237	CcSEcCtD
Pergolide—CYP2D6—brainstem—malignant glioma	0.00105	0.0028	CbGeAlD
Pergolide—Hypertension—Carmustine—malignant glioma	0.00104	0.00237	CcSEcCtD
Pergolide—Palpitations—Temozolomide—malignant glioma	0.00103	0.00234	CcSEcCtD
Pergolide—Myalgia—Carmustine—malignant glioma	0.00103	0.00234	CcSEcCtD
Pergolide—Chest pain—Carmustine—malignant glioma	0.00103	0.00234	CcSEcCtD
Pergolide—Anxiety—Carmustine—malignant glioma	0.00103	0.00233	CcSEcCtD
Pergolide—Cough—Temozolomide—malignant glioma	0.00102	0.00231	CcSEcCtD
Pergolide—HTR2A—telencephalon—malignant glioma	0.00102	0.00273	CbGeAlD
Pergolide—Convulsion—Temozolomide—malignant glioma	0.00101	0.0023	CcSEcCtD
Pergolide—Hypertension—Temozolomide—malignant glioma	0.00101	0.00229	CcSEcCtD
Pergolide—Confusional state—Carmustine—malignant glioma	0.000995	0.00226	CcSEcCtD
Pergolide—Arthralgia—Temozolomide—malignant glioma	0.000995	0.00226	CcSEcCtD
Pergolide—Myalgia—Temozolomide—malignant glioma	0.000995	0.00226	CcSEcCtD
Pergolide—Anxiety—Temozolomide—malignant glioma	0.000991	0.00225	CcSEcCtD
Pergolide—Oedema—Carmustine—malignant glioma	0.000987	0.00224	CcSEcCtD
Pergolide—Discomfort—Temozolomide—malignant glioma	0.000983	0.00223	CcSEcCtD
Pergolide—Infection—Carmustine—malignant glioma	0.00098	0.00222	CcSEcCtD
Pergolide—Dry mouth—Temozolomide—malignant glioma	0.000973	0.00221	CcSEcCtD
Pergolide—HTR1A—central nervous system—malignant glioma	0.000971	0.0026	CbGeAlD
Pergolide—Thrombocytopenia—Carmustine—malignant glioma	0.000966	0.00219	CcSEcCtD
Pergolide—Tachycardia—Carmustine—malignant glioma	0.000963	0.00219	CcSEcCtD
Pergolide—Confusional state—Temozolomide—malignant glioma	0.000961	0.00218	CcSEcCtD
Pergolide—HTR1B—brain—malignant glioma	0.000956	0.00256	CbGeAlD
Pergolide—Oedema—Temozolomide—malignant glioma	0.000954	0.00216	CcSEcCtD
Pergolide—HTR1A—cerebellum—malignant glioma	0.000949	0.00254	CbGeAlD
Pergolide—Infection—Temozolomide—malignant glioma	0.000947	0.00215	CcSEcCtD
Pergolide—ADRA2A—medulla oblongata—malignant glioma	0.000941	0.00252	CbGeAlD
Pergolide—Anorexia—Carmustine—malignant glioma	0.000941	0.00213	CcSEcCtD
Pergolide—Thrombocytopenia—Temozolomide—malignant glioma	0.000934	0.00212	CcSEcCtD
Pergolide—CYP2D6—telencephalon—malignant glioma	0.000928	0.00248	CbGeAlD
Pergolide—HTR1D—brain—malignant glioma	0.000925	0.00248	CbGeAlD
Pergolide—Hypotension—Carmustine—malignant glioma	0.000922	0.00209	CcSEcCtD
Pergolide—Hyperhidrosis—Temozolomide—malignant glioma	0.000922	0.00209	CcSEcCtD
Pergolide—HTR2C—brain—malignant glioma	0.000916	0.00245	CbGeAlD
Pergolide—Anorexia—Temozolomide—malignant glioma	0.000909	0.00206	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000899	0.00204	CcSEcCtD
Pergolide—ADRA1A—central nervous system—malignant glioma	0.000895	0.0024	CbGeAlD
Pergolide—Insomnia—Carmustine—malignant glioma	0.000892	0.00202	CcSEcCtD
Pergolide—Paraesthesia—Carmustine—malignant glioma	0.000886	0.00201	CcSEcCtD
Pergolide—Dyspnoea—Carmustine—malignant glioma	0.00088	0.002	CcSEcCtD
Pergolide—DRD2—central nervous system—malignant glioma	0.000878	0.00235	CbGeAlD
Pergolide—Somnolence—Carmustine—malignant glioma	0.000877	0.00199	CcSEcCtD
Pergolide—ADRA1A—cerebellum—malignant glioma	0.000875	0.00234	CbGeAlD
Pergolide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000869	0.00197	CcSEcCtD
Pergolide—KCNH2—central nervous system—malignant glioma	0.000865	0.00232	CbGeAlD
Pergolide—Insomnia—Temozolomide—malignant glioma	0.000862	0.00196	CcSEcCtD
Pergolide—HTR2B—brain—malignant glioma	0.000861	0.0023	CbGeAlD
Pergolide—ADRA2A—midbrain—malignant glioma	0.00086	0.0023	CbGeAlD
Pergolide—DRD2—cerebellum—malignant glioma	0.000858	0.0023	CbGeAlD
Pergolide—Decreased appetite—Carmustine—malignant glioma	0.000858	0.00195	CcSEcCtD
Pergolide—Paraesthesia—Temozolomide—malignant glioma	0.000856	0.00194	CcSEcCtD
Pergolide—ADRA2C—central nervous system—malignant glioma	0.000853	0.00228	CbGeAlD
Pergolide—Dyspnoea—Temozolomide—malignant glioma	0.00085	0.00193	CcSEcCtD
Pergolide—Somnolence—Temozolomide—malignant glioma	0.000848	0.00192	CcSEcCtD
Pergolide—KCNH2—cerebellum—malignant glioma	0.000845	0.00226	CbGeAlD
Pergolide—Constipation—Carmustine—malignant glioma	0.000844	0.00191	CcSEcCtD
Pergolide—Pain—Carmustine—malignant glioma	0.000844	0.00191	CcSEcCtD
Pergolide—Dyspepsia—Temozolomide—malignant glioma	0.000839	0.0019	CcSEcCtD
Pergolide—ADRA2A—spinal cord—malignant glioma	0.000839	0.00225	CbGeAlD
Pergolide—ADRA2C—cerebellum—malignant glioma	0.000834	0.00223	CbGeAlD
Pergolide—Decreased appetite—Temozolomide—malignant glioma	0.000829	0.00188	CcSEcCtD
Pergolide—Constipation—Temozolomide—malignant glioma	0.000815	0.00185	CcSEcCtD
Pergolide—Pain—Temozolomide—malignant glioma	0.000815	0.00185	CcSEcCtD
Pergolide—Feeling abnormal—Carmustine—malignant glioma	0.000813	0.00184	CcSEcCtD
Pergolide—Gastrointestinal pain—Carmustine—malignant glioma	0.000807	0.00183	CcSEcCtD
Pergolide—HTR2A—medulla oblongata—malignant glioma	0.0008	0.00214	CbGeAlD
Pergolide—Feeling abnormal—Temozolomide—malignant glioma	0.000786	0.00178	CcSEcCtD
Pergolide—Abdominal pain—Carmustine—malignant glioma	0.00078	0.00177	CcSEcCtD
Pergolide—Body temperature increased—Carmustine—malignant glioma	0.00078	0.00177	CcSEcCtD
Pergolide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00078	0.00177	CcSEcCtD
Pergolide—HTR1A—brain—malignant glioma	0.000771	0.00207	CbGeAlD
Pergolide—Body temperature increased—Temozolomide—malignant glioma	0.000754	0.00171	CcSEcCtD
Pergolide—Abdominal pain—Temozolomide—malignant glioma	0.000754	0.00171	CcSEcCtD
Pergolide—HTR2A—midbrain—malignant glioma	0.000731	0.00196	CbGeAlD
Pergolide—HTR2A—spinal cord—malignant glioma	0.000714	0.00191	CbGeAlD
Pergolide—ADRA1A—brain—malignant glioma	0.000711	0.0019	CbGeAlD
Pergolide—Asthenia—Carmustine—malignant glioma	0.000708	0.00161	CcSEcCtD
Pergolide—DRD2—brain—malignant glioma	0.000697	0.00187	CbGeAlD
Pergolide—KCNH2—brain—malignant glioma	0.000687	0.00184	CbGeAlD
Pergolide—Asthenia—Temozolomide—malignant glioma	0.000684	0.00155	CcSEcCtD
Pergolide—ADRA2A—central nervous system—malignant glioma	0.000681	0.00182	CbGeAlD
Pergolide—ADRA2C—brain—malignant glioma	0.000677	0.00181	CbGeAlD
Pergolide—Diarrhoea—Carmustine—malignant glioma	0.000675	0.00153	CcSEcCtD
Pergolide—Pruritus—Temozolomide—malignant glioma	0.000675	0.00153	CcSEcCtD
Pergolide—ADRA2A—cerebellum—malignant glioma	0.000665	0.00178	CbGeAlD
Pergolide—Dizziness—Carmustine—malignant glioma	0.000653	0.00148	CcSEcCtD
Pergolide—Diarrhoea—Temozolomide—malignant glioma	0.000652	0.00148	CcSEcCtD
Pergolide—Dizziness—Temozolomide—malignant glioma	0.000631	0.00143	CcSEcCtD
Pergolide—Vomiting—Carmustine—malignant glioma	0.000627	0.00142	CcSEcCtD
Pergolide—Rash—Carmustine—malignant glioma	0.000622	0.00141	CcSEcCtD
Pergolide—Dermatitis—Carmustine—malignant glioma	0.000622	0.00141	CcSEcCtD
Pergolide—Headache—Carmustine—malignant glioma	0.000618	0.0014	CcSEcCtD
Pergolide—Vomiting—Temozolomide—malignant glioma	0.000606	0.00138	CcSEcCtD
Pergolide—Rash—Temozolomide—malignant glioma	0.000601	0.00136	CcSEcCtD
Pergolide—Dermatitis—Temozolomide—malignant glioma	0.000601	0.00136	CcSEcCtD
Pergolide—Headache—Temozolomide—malignant glioma	0.000597	0.00136	CcSEcCtD
Pergolide—Nausea—Carmustine—malignant glioma	0.000586	0.00133	CcSEcCtD
Pergolide—HTR2A—central nervous system—malignant glioma	0.000579	0.00155	CbGeAlD
Pergolide—Nausea—Temozolomide—malignant glioma	0.000566	0.00129	CcSEcCtD
Pergolide—HTR2A—cerebellum—malignant glioma	0.000566	0.00152	CbGeAlD
Pergolide—ADRA2A—brain—malignant glioma	0.00054	0.00145	CbGeAlD
Pergolide—CYP3A4—central nervous system—malignant glioma	0.000536	0.00144	CbGeAlD
Pergolide—CYP2D6—central nervous system—malignant glioma	0.000527	0.00141	CbGeAlD
Pergolide—CYP2D6—cerebellum—malignant glioma	0.000515	0.00138	CbGeAlD
Pergolide—HTR2A—brain—malignant glioma	0.00046	0.00123	CbGeAlD
Pergolide—CYP2D6—brain—malignant glioma	0.000419	0.00112	CbGeAlD
Pergolide—DRD3—Signaling by GPCR—AKT1—malignant glioma	1.36e-05	7.34e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	1.36e-05	7.32e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—FGF2—malignant glioma	1.36e-05	7.32e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—BRAF—malignant glioma	1.36e-05	7.31e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—malignant glioma	1.36e-05	7.3e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—BCHE—malignant glioma	1.36e-05	7.3e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—malignant glioma	1.36e-05	7.3e-05	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	1.36e-05	7.29e-05	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.36e-05	7.29e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.35e-05	7.29e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL8—malignant glioma	1.35e-05	7.25e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—STAT3—malignant glioma	1.34e-05	7.23e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CASP3—malignant glioma	1.34e-05	7.23e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	1.34e-05	7.22e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL2—malignant glioma	1.34e-05	7.22e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.34e-05	7.21e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	1.34e-05	7.21e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—FGF2—malignant glioma	1.34e-05	7.2e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—malignant glioma	1.33e-05	7.15e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EGFR—malignant glioma	1.33e-05	7.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CB—malignant glioma	1.33e-05	7.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT2—malignant glioma	1.32e-05	7.12e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	1.32e-05	7.09e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—malignant glioma	1.31e-05	7.06e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	1.31e-05	7.05e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—FGF2—malignant glioma	1.31e-05	7.05e-05	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.31e-05	7.04e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—malignant glioma	1.31e-05	7.04e-05	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	1.3e-05	7.01e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.3e-05	6.99e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.3e-05	6.98e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL2—malignant glioma	1.29e-05	6.97e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	1.29e-05	6.94e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CASP3—malignant glioma	1.29e-05	6.94e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL2—malignant glioma	1.29e-05	6.93e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—malignant glioma	1.28e-05	6.88e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EGFR—malignant glioma	1.28e-05	6.88e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	1.28e-05	6.87e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MDM2—malignant glioma	1.27e-05	6.85e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.27e-05	6.84e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—malignant glioma	1.27e-05	6.83e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RAF1—malignant glioma	1.27e-05	6.82e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—STAT3—malignant glioma	1.27e-05	6.82e-05	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	1.27e-05	6.81e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—malignant glioma	1.26e-05	6.79e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	1.26e-05	6.79e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PTEN—malignant glioma	1.26e-05	6.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.26e-05	6.78e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	1.26e-05	6.76e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CASP3—malignant glioma	1.25e-05	6.75e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB2—malignant glioma	1.25e-05	6.75e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.25e-05	6.75e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL2—malignant glioma	1.25e-05	6.74e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MDM2—malignant glioma	1.25e-05	6.74e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—malignant glioma	1.25e-05	6.73e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—malignant glioma	1.25e-05	6.73e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—malignant glioma	1.25e-05	6.72e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RAF1—malignant glioma	1.25e-05	6.71e-05	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	1.25e-05	6.71e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.24e-05	6.7e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CB—malignant glioma	1.24e-05	6.66e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CAV1—malignant glioma	1.24e-05	6.66e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CASP3—malignant glioma	1.23e-05	6.64e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB2—malignant glioma	1.23e-05	6.64e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL2—malignant glioma	1.23e-05	6.63e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	1.23e-05	6.62e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.23e-05	6.62e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—malignant glioma	1.23e-05	6.61e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.23e-05	6.61e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.23e-05	6.6e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.23e-05	6.59e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.22e-05	6.57e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—malignant glioma	1.22e-05	6.57e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—malignant glioma	1.22e-05	6.56e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.22e-05	6.55e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	1.22e-05	6.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.22e-05	6.55e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PTEN—malignant glioma	1.21e-05	6.52e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.21e-05	6.5e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—KRAS—malignant glioma	1.21e-05	6.5e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.19e-05	6.42e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—malignant glioma	1.19e-05	6.4e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.19e-05	6.39e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—malignant glioma	1.19e-05	6.38e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.18e-05	6.36e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.18e-05	6.34e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—malignant glioma	1.18e-05	6.33e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—malignant glioma	1.17e-05	6.3e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—malignant glioma	1.17e-05	6.28e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—malignant glioma	1.16e-05	6.25e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—malignant glioma	1.16e-05	6.25e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PTEN—malignant glioma	1.16e-05	6.24e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—KRAS—malignant glioma	1.15e-05	6.21e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.15e-05	6.2e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—malignant glioma	1.15e-05	6.2e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.15e-05	6.19e-05	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.15e-05	6.18e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.15e-05	6.17e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTEN—malignant glioma	1.15e-05	6.16e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.14e-05	6.15e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1.14e-05	6.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.14e-05	6.13e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP3—malignant glioma	1.14e-05	6.13e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL2—malignant glioma	1.14e-05	6.12e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1.14e-05	6.11e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—malignant glioma	1.14e-05	6.11e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.13e-05	6.11e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.13e-05	6.09e-05	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.13e-05	6.08e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—malignant glioma	1.13e-05	6.07e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.13e-05	6.07e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.13e-05	6.06e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.12e-05	6.04e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP3—malignant glioma	1.12e-05	6.03e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL2—malignant glioma	1.12e-05	6.02e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—malignant glioma	1.11e-05	6e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PIK3CA—malignant glioma	1.11e-05	5.97e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.11e-05	5.96e-05	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.11e-05	5.96e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.1e-05	5.92e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.1e-05	5.9e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.1e-05	5.89e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—malignant glioma	1.09e-05	5.89e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—malignant glioma	1.09e-05	5.87e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.09e-05	5.86e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—KRAS—malignant glioma	1.09e-05	5.85e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—malignant glioma	1.09e-05	5.85e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—malignant glioma	1.08e-05	5.83e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.08e-05	5.81e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—malignant glioma	1.08e-05	5.79e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—malignant glioma	1.07e-05	5.78e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—KRAS—malignant glioma	1.07e-05	5.78e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—KRAS—malignant glioma	1.07e-05	5.78e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PTEN—malignant glioma	1.07e-05	5.76e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.06e-05	5.73e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	1.06e-05	5.73e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	1.06e-05	5.7e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.06e-05	5.7e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—malignant glioma	1.05e-05	5.67e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.05e-05	5.66e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAT—malignant glioma	1.05e-05	5.65e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—malignant glioma	1.05e-05	5.64e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.05e-05	5.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—malignant glioma	1.04e-05	5.61e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.04e-05	5.58e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.04e-05	5.58e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.03e-05	5.54e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.03e-05	5.53e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.03e-05	5.52e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—malignant glioma	1.03e-05	5.52e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—malignant glioma	1.03e-05	5.52e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.02e-05	5.48e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.02e-05	5.48e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—malignant glioma	1.01e-05	5.45e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—malignant glioma	1.01e-05	5.42e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.01e-05	5.41e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PIK3CA—malignant glioma	9.99e-06	5.38e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3CA—malignant glioma	9.95e-06	5.35e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NCOR1—malignant glioma	9.92e-06	5.34e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CD—malignant glioma	9.91e-06	5.33e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—malignant glioma	9.9e-06	5.33e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	9.86e-06	5.31e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PIK3CA—malignant glioma	9.86e-06	5.31e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—malignant glioma	9.85e-06	5.3e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—malignant glioma	9.8e-06	5.27e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—KRAS—malignant glioma	9.69e-06	5.21e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—malignant glioma	9.67e-06	5.2e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—malignant glioma	9.66e-06	5.2e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—malignant glioma	9.64e-06	5.19e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—malignant glioma	9.63e-06	5.18e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—malignant glioma	9.58e-06	5.16e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PTEN—malignant glioma	9.58e-06	5.15e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—malignant glioma	9.57e-06	5.15e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—malignant glioma	9.54e-06	5.13e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—malignant glioma	9.54e-06	5.13e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—malignant glioma	9.51e-06	5.11e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—malignant glioma	9.43e-06	5.07e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—malignant glioma	9.41e-06	5.06e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—malignant glioma	9.41e-06	5.06e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—KRAS—malignant glioma	9.35e-06	5.03e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	9.34e-06	5.03e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	9.31e-06	5.01e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—KRAS—malignant glioma	9.31e-06	5.01e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—malignant glioma	9.22e-06	4.96e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—malignant glioma	9.22e-06	4.96e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—malignant glioma	9.07e-06	4.88e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—KRAS—malignant glioma	9.05e-06	4.87e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—KRAS—malignant glioma	8.91e-06	4.79e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	8.9e-06	4.79e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—malignant glioma	8.89e-06	4.78e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—malignant glioma	8.75e-06	4.71e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—malignant glioma	8.69e-06	4.68e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—malignant glioma	8.66e-06	4.66e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	8.65e-06	4.65e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CB—malignant glioma	8.64e-06	4.65e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—malignant glioma	8.61e-06	4.63e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	8.59e-06	4.62e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—malignant glioma	8.56e-06	4.61e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—malignant glioma	8.56e-06	4.61e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—malignant glioma	8.56e-06	4.6e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—malignant glioma	8.55e-06	4.6e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	8.55e-06	4.6e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—malignant glioma	8.38e-06	4.51e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	8.32e-06	4.47e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—malignant glioma	8.31e-06	4.47e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—malignant glioma	8.27e-06	4.45e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KRAS—malignant glioma	8.21e-06	4.42e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	8.18e-06	4.4e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—malignant glioma	8.16e-06	4.39e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—malignant glioma	8.12e-06	4.37e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAV1—malignant glioma	8.09e-06	4.35e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KRAS—malignant glioma	8.08e-06	4.35e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CA—malignant glioma	8.08e-06	4.35e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—malignant glioma	8.06e-06	4.33e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—malignant glioma	8.06e-06	4.33e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—malignant glioma	8.05e-06	4.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—malignant glioma	7.96e-06	4.28e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—malignant glioma	7.92e-06	4.26e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KRAS—malignant glioma	7.91e-06	4.26e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—malignant glioma	7.78e-06	4.19e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CA—malignant glioma	7.55e-06	4.06e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTEN—malignant glioma	7.46e-06	4.01e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	7.42e-06	3.99e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.37e-06	3.96e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KRAS—malignant glioma	7.35e-06	3.96e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—malignant glioma	7.3e-06	3.93e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—malignant glioma	7.27e-06	3.91e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	7.27e-06	3.91e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—malignant glioma	7.18e-06	3.86e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—malignant glioma	7.11e-06	3.83e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—malignant glioma	7.03e-06	3.78e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—malignant glioma	7.02e-06	3.78e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.98e-06	3.76e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—malignant glioma	6.79e-06	3.66e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	6.75e-06	3.63e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—malignant glioma	6.69e-06	3.6e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—malignant glioma	6.6e-06	3.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—malignant glioma	6.53e-06	3.52e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.48e-06	3.49e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—malignant glioma	6.16e-06	3.32e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—malignant glioma	6.07e-06	3.26e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.94e-06	3.2e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.65e-06	3.04e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—malignant glioma	5.59e-06	3.01e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—malignant glioma	5.52e-06	2.97e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CA—malignant glioma	5.26e-06	2.83e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTEN—malignant glioma	4.88e-06	2.62e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—malignant glioma	4.3e-06	2.31e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.44e-06	1.85e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—malignant glioma	2.81e-06	1.51e-05	CbGpPWpGaD
